Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker Profiling of Mycosis Fungoides Patients Treated with Chlormethine Gel
NCT05303480Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mechlorethamine in mycosis fungoides (MF), sponsored by Centre for Human Drug Research. Primary endpoints: Composite Assessment of Index Lesions at day 155 and Modified Severity Weighted Assessment Tool at day 155. Started Dec 2021; status: completed.
02
Drugs
mechlorethamine
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT05303480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05303480.